share_log

Well Lead Medical Co., Ltd.'s (SHSE:603309) Market Cap Dropped CN¥381m Last Week; Private Companies Bore the Brunt

Well Lead Medical Co., Ltd.'s (SHSE:603309) Market Cap Dropped CN¥381m Last Week; Private Companies Bore the Brunt

威利德醫療有限公司's(SHSE: 603309)上週市值下降了3.81億元人民幣;私營公司首當其衝
Simply Wall St ·  03/27 23:15

Key Insights

關鍵見解

  • The considerable ownership by private companies in Well Lead Medical indicates that they collectively have a greater say in management and business strategy
  • A total of 3 investors have a majority stake in the company with 50% ownership
  • 19% of Well Lead Medical is held by Institutions
  • 私營公司對Well Lead Medical的大量所有權表明,它們在管理和業務戰略中集體擁有更大的發言權
  • 共有3名投資者持有該公司的多數股權,所有權爲50%
  • Well Lead Medical 19% 的股份由機構持有

To get a sense of who is truly in control of Well Lead Medical Co., Ltd. (SHSE:603309), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 51% to be precise, is private companies. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

要了解誰真正控制了Well Lead Medical Co., Ltd.(SHSE: 603309),了解該業務的所有權結構非常重要。持有該公司股份最多的集團是私營公司,準確地說約爲51%。也就是說,如果股票上漲,該集團將受益最大(如果股價下跌,則損失最大)。

As market cap fell to CN¥3.1b last week, private companies would have faced the highest losses than any other shareholder groups of the company.

隨着上週市值跌至31億元人民幣,私營公司面臨的損失將超過該公司任何其他股東群體。

Let's take a closer look to see what the different types of shareholders can tell us about Well Lead Medical.

讓我們仔細看看不同類型的股東能告訴我們關於Well Lead Medical的什麼。

ownership-breakdown
SHSE:603309 Ownership Breakdown March 28th 2024
SHSE: 603309 所有權明細 2024 年 3 月 28 日

What Does The Institutional Ownership Tell Us About Well Lead Medical?

關於Well Lead Medical,機構所有權告訴我們什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構根據近似於當地市場的指數來衡量自己的表現。因此,他們通常會更多地關注主要指數中包含的公司。

We can see that Well Lead Medical does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Well Lead Medical, (below). Of course, keep in mind that there are other factors to consider, too.

我們可以看到,Well Lead Medical確實有機構投資者;他們持有該公司很大一部分股票。這可能表明該公司在投資界具有一定程度的信譽。但是,最好謹慎行事,不要依賴機構投資者所謂的驗證。他們也是,有時候會弄錯。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得查看Well Lead Medical過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SHSE:603309 Earnings and Revenue Growth March 28th 2024
SHSE: 603309 2024 年 3 月 28 日收益和收入增長

Hedge funds don't have many shares in Well Lead Medical. The company's largest shareholder is Coplex Investment (Hong Kong) Limited, with ownership of 31%. Meanwhile, the second and third largest shareholders, hold 13% and 5.3%, of the shares outstanding, respectively.

對沖基金在Well Lead Medical的股票不多。該公司的最大股東是Coplex投資(香港)有限公司,所有權爲31%。同時,第二和第三大股東分別持有已發行股份的13%和5.3%。

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 50% stake.

對股東登記冊的更詳細研究表明,前三名股東通過其50%的股份擁有公司的大量所有權。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。儘管有一些分析師的報道,但該公司的報道可能並不廣泛。因此,在未來它可能會引起更多關注。

Insider Ownership Of Well Lead Medical

威利德醫療的內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

儘管內部人士的確切定義可能是主觀的,但幾乎每個人都認爲董事會成員是內部人士。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。

Our information suggests that Well Lead Medical Co., Ltd. insiders own under 1% of the company. However, it's possible that insiders might have an indirect interest through a more complex structure. It seems the board members have no more than CN¥5.0m worth of shares in the CN¥3.1b company. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.

我們的信息表明,Well Lead Medical Co., Ltd.內部人士擁有該公司不到1%的股份。但是,內部人士有可能通過更復雜的結構獲得間接利益。看來董事會成員在這家31億元人民幣的公司中持有的股份不超過500萬元人民幣。許多小型公司的投資者更願意看到董事會加大投資力度。你可以點擊這裏查看這些內部人士是否在買入或賣出。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 29% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

包括散戶投資者在內的公衆擁有該公司29%的股份,因此不容忽視。儘管這種所有權規模可能不足以影響對他們有利的政策決定,但它們仍然可以對公司政策產生集體影響。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 51%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們的數據顯示,私營公司持有公司51%的股份。私營公司可能是關聯方。有時,內部人士通過控股私營公司而對上市公司擁有權益,而不是以個人身份擁有權益。儘管很難得出任何寬泛的結論,但值得注意的是,這是一個需要進一步研究的領域。

Next Steps:

後續步驟:

It's always worth thinking about the different groups who own shares in a company. But to understand Well Lead Medical better, we need to consider many other factors. For instance, we've identified 1 warning sign for Well Lead Medical that you should be aware of.

擁有公司股份的不同群體總是值得考慮的。但是,爲了更好地了解Well Lead Medical,我們需要考慮許多其他因素。例如,我們已經確定了Well Lead Medical的1個警告信號,你應該注意這一點。

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

歸根結底,未來是最重要的。您可以訪問這份關於公司分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論